11/11/2008:
Charlesson selected to receive two-year funding from Oklahoma EDGE

11/04/2008:
Charlesson Senior Vice-President, Dr. Mostafa Analoui, to speak at the 21st Century Medicine: Breakthroughs and Challenges Conference

10/21/2008:
Charlesson Senior Vice-President, Dr. Mostafa Analoui, to speak at the 13th Annual Drug Delivery Partnerships Meeting

08/01/2008:
Charlesson Senior Vice-President, Dr. Mostafa Analoui, to speak at the 13th Annual World Congress of Drug Discovery & Development of Innovative Therapeutics.

07/22/2008:
Charlesson scientist, Dr. Rafal Farjo, receives $241,000 Phase I SBIR grant from the National Institutes of Health to develop CLT-005 for Retinal Inflammation and Neovascularization

07/10/2008:
Charlesson selected to compete for Oklahoma EDGE funding.

06/05/2008:
Mike Moradi, CEO of Charlesson, featured in The Oklahoman

05/22/2008:
Charlesson scientist, Dr. Ying Chen, receives $90,000 award from the Oklahoma Center for Advancement in Science and Technology to develop CLT-009 as a treatment for Age-Related Macular Degeneration

04/23/2008:
Charlesson scientist, Dr. Drew Wassel, receives $204,280 award from the Oklahoma Center for Advancement in Science and Technology to develop nanoparticle drug formulations

04/21/2008:
Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology

04/17/2008:
Charlesson announces upcoming presentations at the 2008 annual meeting of the Assoication for Research in Vision and Ophthlamology (ARVO).

03/11/2008:
Charlesson scientist, Dr. Rafal Farjo, receives $1,388,000 Phase II SBIR grant from the National Insitutues of Health to develop CLT-004 for Diabetic Retinopathy and Age-Related Macular Degeneration.

01/17/2008:
Charlesson selected to receive The Journal Record Innovator of the Year "On the Brink" Award

01/11/2008:
Charlesson scientist, Dr. Rafal Farjo, receives $210,000 Phase I SBIR grant from the National Insitutues of Health to develop new models for Age-Related Macular Degeneration

10/15/2007:
Ocular Pharmaceutical Company Charlesson Announces $2.35MM in New Funding

09/26/2007:
Charlesson receives $1,141,000 grant from the National Institutes of Health to develop nanotechnology-based treatments for Diabetic Retinopathy

09/17/2007:
Charlesson scientist, Dr. Danyang Chen, receives $840,000 Phase II SBIR grant from the National Institutes of Health to develop CLT-003 for the treatment of Diabetic Macular Edema

09/05/2007:
Charlesson selected as a Finalist for the 2007 Grace & Franklin Bernsen most promising new business award

08/13/2007:
Charlesson  scientist, Dr. Rafal Farjo, featured as an expert guest on Oklahoma Innovations Radio Show.  Click here to listen to the broadcast

05/22/2007:
Charlesson scientist, Dr. Rafal Farjo, receives $135,000 grant from the Oklahoma Center for Advancement of Science and Technology to develop gene therapy treatments for blinding diseases